Published in Epidemiol Rev on January 01, 1996
Molecular epidemiological analysis of Cryptosporidium spp. in the United Kingdom: results of genotyping Cryptosporidium spp. in 1,705 fecal samples from humans and 105 fecal samples from livestock animals. J Clin Microbiol (2000) 3.57
Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev (2002) 2.67
Molecular characterization of cryptosporidium oocysts in samples of raw surface water and wastewater. Appl Environ Microbiol (2001) 2.58
Distribution of cryptosporidium genotypes in storm event water samples from three watersheds in New York. Appl Environ Microbiol (2005) 2.27
Molecular characterization of Cryptosporidium isolates obtained from humans in France. J Clin Microbiol (2001) 2.05
Cost of illness in the 1993 waterborne Cryptosporidium outbreak, Milwaukee, Wisconsin. Emerg Infect Dis (2003) 2.01
Concentrated swine feeding operations and public health: a review of occupational and community health effects. Environ Health Perspect (2000) 1.93
Cryptosporidium pathogenicity and virulence. Clin Microbiol Rev (2013) 1.66
Clean drinking water for homes in Africa and other less developed countries. BMJ (2005) 1.54
Cryptosporidiosis in paediatric renal transplantation. Pediatr Nephrol (2009) 1.50
Cryptosporidium parvum infection involving novel genotypes in wildlife from lower New York State. Appl Environ Microbiol (2001) 1.33
Sporadic cryptosporidiosis, North Cumbria, England, 1996-2000. Emerg Infect Dis (2004) 1.30
Outbreaks of waterborne infectious intestinal disease in England and Wales, 1992-2003. Epidemiol Infect (2006) 1.27
Foot and mouth disease in livestock and reduced cryptosporidiosis in humans, England and Wales. Emerg Infect Dis (2003) 1.18
Nested polymerase chain reaction for amplification of the Cryptosporidium oocyst wall protein gene. Emerg Infect Dis (2001) 1.15
Foot and mouth disease and cryptosporidiosis: possible interaction between two emerging infectious diseases. Emerg Infect Dis (2003) 1.07
Multilocus analysis of Cryptosporidium hominis and Cryptosporidium parvum isolates from sporadic and outbreak-related human cases and C. parvum isolates from sporadic livestock cases in the United Kingdom. J Clin Microbiol (2007) 1.06
Cryptosporidiosis: An under-recognized public health problem. Trop Parasitol (2012) 1.05
Intra-isolate variation of Cryptosporidium parvum small subunit ribosomal RNA genes from human hosts in England. Parasitol Res (2003) 0.93
Serological evidence of Cryptosporidium infections in southern Europe. Eur J Epidemiol (2000) 0.93
Signature-forecasting and early outbreak detection system. Environmetrics (2005) 0.88
Evaluation of a screening test for detection of giardia and cryptosporidium parasites. J Clin Microbiol (2008) 0.88
Risk factor analysis and spatiotemporal CART model of cryptosporidiosis in Queensland, Australia. BMC Infect Dis (2010) 0.87
Detection of Cryptosporidium parvum in horses: thresholds of acid-fast stain, immunofluorescence assay, and flow cytometry. J Clin Microbiol (1999) 0.87
The use of ZIP and CART to model cryptosporidiosis in relation to climatic variables. Int J Biometeorol (2010) 0.86
An outbreak of Cryptosporidium hominis infection at an Illinois recreational waterpark. Epidemiol Infect (2006) 0.85
The Risk of Reported Cryptosporidiosis in Children Aged <5 Years in Australia is Highest in Very Remote Regions. Int J Environ Res Public Health (2015) 0.85
Comparison of microscopy, rapid immunoassay, and molecular techniques for the detection of Giardia lamblia and Cryptosporidium parvum. Parasitol Res (2013) 0.84
Perceived causes of sporadic cryptosporidiosis and their relation to sources of information. J Epidemiol Community Health (2006) 0.83
Sporadic cryptosporidiosis decline after membrane filtration of public water supplies, England, 1996-2002. Emerg Infect Dis (2005) 0.83
Cryptosporidium infection: diagnostic techniques. Parasitol Res (2005) 0.83
Molecular epidemiological analysis of Cryptosporidium isolates from humans and animals by using a heteroduplex mobility assay and nucleic acid sequencing based on a small double-stranded RNA element. J Clin Microbiol (2003) 0.82
Food and drinking water hygiene and intestinal protozoa in deployed German soldiers. Eur J Microbiol Immunol (Bp) (2013) 0.82
Patterns of protozoan infections: spatiotemporal associations with cattle density. Ecohealth (2010) 0.81
PCR-restriction fragment length polymorphism analysis of a diagnostic 452-base-pair DNA fragment discriminates between Cryptosporidium parvum and C. meleagridis and between C. parvum isolates of human and animal origin. Appl Environ Microbiol (2002) 0.80
Prevalence, species identification and genotyping Cryptosporidium from livestock and deer in a catchment in the Cairngorms with a history of a contaminated public water supply. Parasit Vectors (2015) 0.78
Evaluation of recombinant oocyst protein CP41 for detection of cryptosporidium-specific antibodies. Clin Diagn Lab Immunol (2005) 0.78
Cryptosporidium spp. Infection in human and domestic animals. Iran J Parasitol (2012) 0.78
Significantly higher occurrence of Cryptosporidium infection in Roma children compared with non-Roma children in Slovakia. Eur J Clin Microbiol Infect Dis (2014) 0.77
Cryptosporidium parvum induces SIRT1 expression in host epithelial cells through downregulating let-7i. Hum Immunol (2014) 0.76
Oxidative stress control by apicomplexan parasites. Biomed Res Int (2015) 0.76
Bayesian classification and regression trees for predicting incidence of cryptosporidiosis. PLoS One (2011) 0.76
Coccidian intestinal parasites among immunocompetent children presenting with diarrhea: Are we missing them? Trop Parasitol (2017) 0.75
Increased stool sampling during a waterborne outbreak of cryptosporidiosis does not increase the detection of other faecal pathogens. J Clin Pathol (2002) 0.75
The Prevalence of Cryptosporidium spp. in Children, Taiz District, Yemen. Iran J Parasitol (2010) 0.75
PCR-RFLP analysis of the Cryptosporidium oocyst wall protein (COWP) gene discriminates between C. wrairi and C. parvum, and between C. parvum isolates of human and animal origin. FEMS Microbiol Lett (1997) 5.09
Laboratory diagnosis of cryptosporidiosis. J Clin Pathol (1985) 2.90
Cryptosporidium species a "new" human pathogen. J Clin Pathol (1985) 2.63
Improved survival for patients with acute myelogenous leukemia. J Clin Oncol (1995) 2.30
Familial abnormalities of suppressor-cell function in systemic lupus erythematosus. N Engl J Med (1979) 1.87
Catastrophic hemorrhage on sternal reentry: still a dreaded complication? Ann Thorac Surg (1999) 1.80
Identification of cryptosporidium oocysts by monoclonal antibody. Lancet (1987) 1.79
Outbreaks of waterborne infectious intestinal disease in England and Wales, 1992-5. Epidemiol Infect (1998) 1.74
Gentamicin as a bactericidal agent in virological tissue cultures. J Clin Pathol (1967) 1.71
Sporadic cryptosporidiosis in children. Lancet (1983) 1.69
Hypothesis: cryptosporidiosis in human beings is not primarily a zoonosis. J Infect (1984) 1.62
Molecular characterisation of Cryptosporidium parvum from two large suspected waterborne outbreaks. Outbreak Control Team South and West Devon 1995, Incident Management Team and Further Epidemiological and Microbiological Studies Subgroup North Thames 1997. Commun Dis Public Health (1998) 1.54
Pulmonary complications of bone marrow transplantation. Chest (1996) 1.50
Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid. Am J Hematol (1994) 1.42
Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation. Cancer (1999) 1.41
Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation. Biol Blood Marrow Transplant (1999) 1.39
Sensitivity of Hartmannella (Acanthamoeba) to 5-fluorocytosine, hydroxystilbamidine, and other substances. J Clin Pathol (1970) 1.39
Long-term outcome of bulimia nervosa. Arch Gen Psychiatry (1999) 1.36
Genetic and environmental influences on anorexia nervosa syndromes in a population-based twin sample. Psychol Med (2001) 1.32
Bilomas: a new approach to the diagnosis and treatment. Gastrointest Radiol (1983) 1.29
Modification of a rapid method for the identification of gene-specific polymorphisms in Cryptosporidium parvum and its application to clinical and epidemiological investigations. Appl Environ Microbiol (2001) 1.21
Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant (2007) 1.21
Cryptosporidium plus Campylobacter: an outbreak in a semi-rural population. J Hyg (Lond) (1986) 1.19
An outbreak of waterborne cryptosporidiosis associated with a public water supply in the UK. Epidemiol Infect (1995) 1.16
The epidemiology of cryptosporidiosis: application of experimental sub-typing and antibody detection systems to the investigation of water-borne outbreaks. Folia Parasitol (Praha) (1998) 1.13
Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant (2000) 1.09
Cryptosporidium and the safety of our water supplies. Commun Dis Public Health (1998) 1.05
Unusual roentgenologic manifestations of Meckel's diverticulum. Gastrointest Radiol (1981) 1.00
Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation. Blood (2001) 0.98
Vancomycin-resistant enterococcal infections in bone marrow transplant recipients. Bone Marrow Transplant (1998) 0.96
The antibody response to Cryptosporidium: development of a serological test and its use in a study of immunologically normal persons. J Infect (1987) 0.95
A reassessment of the phosphoglycerate bypass enzymes in human erythrocytes. Biochem Biophys Res Commun (1975) 0.95
Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant (2005) 0.95
Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. Blood (2001) 0.95
The association of interleukin 6 with clinical and laboratory parameters of acute pelvic inflammatory disease. Am J Obstet Gynecol (1999) 0.93
Treatment of acute myeloid leukemia in the elderly with low-dose cytarabine, hydroxyurea, and calcitriol. Am J Hematol (1992) 0.93
Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clin Infect Dis (1999) 0.92
A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant (2003) 0.91
Extracorporeal photopheresis in chronic graft-versus-host disease. Bone Marrow Transplant (2002) 0.90
Nifedipine as a therapeutic modality for Raynaud's phenomenon. Arthritis Rheum (1983) 0.90
Social adjustment over 10 years following diagnosis with bulimia nervosa. Int J Eat Disord (2000) 0.89
Clinical predictors of infection of central venous catheters used for total parenteral nutrition. Infect Control Hosp Epidemiol (1990) 0.89
A comparison of some of the physical and chemical properties of the phosphoglycerate mutases from human erythrocytes. Biochem Biophys Res Commun (1976) 0.89
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. Blood (1998) 0.87
Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia. Cancer (1985) 0.86
Contamination of virological tissue cultures with a species of free-living soil amoeba. J Clin Pathol (1969) 0.85
Hyperleukocytosis during induction therapy with arsenic trioxide for relapsed acute promyelocytic leukemia associated with central nervous system infarction. Blood (2000) 0.85
Accelerated bone formation causing profound hypocalcemia in acute leukemia. Ann Intern Med (1986) 0.85
Prospective study of catheter replacement and other risk factors for infection of hyperalimentation catheters. J Infect Dis (1986) 0.85
Cryptosporidiosis associated with a swimming pool complex. Commun Dis Rep CDR Rev (1994) 0.84
Free-living amoebae in home dialysis unit. Lancet (1977) 0.84
Increased incidence of hypothyroidism in primary biliary cirrhosis. Dig Dis Sci (1983) 0.84
Acanthamoeba keratitis. J Clin Pathol (1992) 0.84
Rhabdomyolysis associated with high-dose cytarabine. Cancer Treat Rep (1987) 0.84
Plasma catecholamine metabolites in subtypes of major depression. Biol Psychiatry (1987) 0.83
Genetic abnormalities of immunoregulation in primary biliary cirrhosis. Am J Med (1983) 0.83
Gaucher's disease and chronic lymphocytic leukemia. Possible pathogenetic link between Gaucher's disease and B-cell proliferations? Cancer (1984) 0.83
Preservation of cocoa antioxidant activity, total polyphenols, flavan-3-ols, and procyanidin content in foods prepared with cocoa powder. J Food Sci (2009) 0.82
Detection of a picobirnavirus associated with Cryptosporidium positive stools from humans. Arch Virol (1995) 0.82
Predictive validity of bulimia nervosa as a diagnostic category. Am J Psychiatry (2000) 0.82
Nifedipine-induced fingertip vasodilation in patients with Raynaud's phenomenon. Am Heart J (1984) 0.82
The role of delayed hypersensitivity in the enhancement of host resistance to infection. Can J Microbiol (1980) 0.81
Histocompatibility antigens in primary biliary cirrhosis. Am J Gastroenterol (1987) 0.81
Enhanced responses to L-arginine in aortic rings from rats with angiotensin-dependent hypertension. J Pharmacol Exp Ther (1995) 0.81
The effect of acute discontinuation of total parenteral nutrition. Ann Surg (1986) 0.80
Degeneration of axons in the corticospinal tract secondary to spinal cord ischemia in rats. Paraplegia (1995) 0.80
A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT. Bone Marrow Transplant (2010) 0.80
Nosocomial klebsiella infection in a neonatal unit: identification of risk factors for gastrointestinal colonization. Infect Control (1981) 0.80
A Cryptosporidium hominis outbreak in north-west Wales associated with low oocyst counts in treated drinking water. J Water Health (2009) 0.80
Pneumocystis carinii pneumonia as a complication of desferrioxamine therapy. Br J Haematol (1988) 0.79
Autoimmunity and suppressor T lymphocytes. Adv Intern Med (1982) 0.79
Ultrasonic demonstration of splenic rupture in infectious mononucleosis. J Clin Ultrasound (1982) 0.79
Normal immunoregulation of in vitro antibody secretion in autoimmune thyroid disease. J Clin Endocrinol Metab (1981) 0.79
Immunotherapy with autologous bone-marrow transplantation: rationale and results. Exp Hematol (1994) 0.79
Rapid desensitisation for desferrioxamine anaphylactic reaction. Lancet (1981) 0.79
Immune regulatory abnormalities produced by procainamide. Am J Med (1982) 0.79
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation. Bone Marrow Transplant (2001) 0.78
Evidence for structural homology between human red cell phosphoglycerate mutase and 2,3-bisphosphoglycerate synthase. J Biol Chem (1978) 0.78
Vascular responsiveness to nitric oxide synthesis inhibition in hypertensive rats. Hypertension (1994) 0.78
Cryptosporidiosis in Great Yarmouth--the investigation of an outbreak. Public Health (1989) 0.78
Waldenström's macroglobulinemia with an IgM paraprotein that is both a cold agglutinin and a cryoglobulin and has a suppressive effect on progenitor cell growth. Transfusion (1994) 0.78
Calcium- and protein kinase C-dependent basal tone in the aorta of hypertensive rats. Hypertension (1995) 0.78
A phase II trial of autologous bone marrow transplantation (ABMT) in acute leukemia with edelfosine purged bone marrow. Adv Exp Med Biol (1996) 0.77
A simple SDS-PAGE immunoblotting technique using an enhanced chemiluminescence detection system to identify polyclonal antibody responses to complex cryptosporidial antigen preparations following a monoclonal antibody retest and image overlay technique. J Immunol Methods (1997) 0.77
High degree of occult tumor contamination in bone marrow and peripheral blood stem cells of patients undergoing autologous transplantation for non-Hodgkin's lymphoma. Biol Blood Marrow Transplant (1996) 0.76
Cognitive-behavioral therapy for subthreshold bulimia nervosa: A case series. Eat Weight Disord (2011) 0.76
Large-volume leukapheresis for collection of mononuclear cells for hematopoietic rescue in Hodgkin's disease. Transfusion (1995) 0.76
Timing of symptoms and oocyst excretion in human cryptosporidiosis. N Engl J Med (1987) 0.76
Cowpox in a child, acquired from a cat. Clin Exp Dermatol (1987) 0.76
Cryptosporidium and diarrhoea. Br Med J (Clin Res Ed) (1986) 0.76
Hospital-acquired cryptosporidiosis. Commun Dis Rep CDR Rev (1992) 0.76
Cyclospora: another "new" pathogen. J Med Microbiol (1994) 0.76
Is human cryptosporidiosis a zoonotic disease? Lancet (1993) 0.75
Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity? Arch Gen Psychiatry (1987) 0.75
Cyclospora species as a cause of diarrhoea in humans. Br J Biomed Sci (1999) 0.75
Shedding of oocysts of Cryptosporidium in immunocompetent patients. J Clin Pathol (1989) 0.75
Letter: Serum immunoglobulins in herpes virus infections. Br Med J (1975) 0.75
latrogenic pseudoaneurysm of the innominate artery. Tex Heart Inst J (1992) 0.75
Cholestatic jaundice and aminoglutethimide. Ann Intern Med (1982) 0.75